PP
Pilar de la Puente

Publications (1)

MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
Article scientifique · 2016

Domaines principaux

Sciences de la santé1

Statistiques

Consultations2
Téléchargements0